3d Systems's biggest risks in the FY2024 10-K
- Revenue concentration with large clients creates significant vulnerability for financial results.
- Regulatory compliance issues across medical devices, export controls, and chemicals impose ongoing operational burdens.
- Delays in the inbound supply chain and sole-source dependencies threaten product fulfillment.
The risks most specific to 3d Systems
The loss of, continued reduction or substantial decline in revenue from larger clients could have a material adverse effect on our revenues, profitability and liquidity
A large customer represented 16% of consolidated revenue in 2024, and losing such major clients would severely harm our business.
Our uneven sales cycle makes planning and inventory management difficult and future financial results less predictable
Our quarterly hardware and software sales disproportionately occur near the end of each quarter, complicating planning and inventory management.
We purchase components and sub-assemblies for our printers from third-party suppliers that we provide to our customers as spare parts. Additionally, we purchase raw chemicals and packaging that are used in our materials, as well as certain of those materials, from third-party suppliers
We rely on sole or limited-source third-party suppliers for critical components like lasers, materials, and jetting components.
The success of our regenerative medicine efforts depends on developing and commercializing products, either ourselves or in conjunction with development partners, that are subject to technical and market risks
Our regenerative medicine program for human organ transplantation and drug discovery requires significant investment with no guarantee of success.
We are subject to complex government laws and regulations relating to certain product sets and failure to meet the stringent requirements could impact our business operations and financial position
Our medical device business is subject to extensive FDA regulations and complex approval processes for market entry.
In February 2023, the Company settled these matters with all three agencies. See Note 22, “Commitments and Contingencies,” to our consolidated financial statements included in Part II, Item 8, “Financial Statements and Supplementary Data” of this Form 10-K for additional information
We must comply with negotiated settlement agreements requiring strengthened export compliance programs, failing which we face monetary penalties.
We are no longer eligible to use a Form S-3 registration statement, which could impair our capital-raising activities
Our failure to timely file financial reports has rendered us ineligible to use Form S-3 registration statements, impairing capital-raising.
All 25 risk factors
Headings as the filing states them, in filing order.
Other
- 01Operational & Financial Risk Factors
- 02The loss of, continued reduction or substantial decline in revenue from larger clients could have a material adverse effect on our revenues, profitability and liquidity
- 03Changes in business conditions may cause our goodwill, intangible assets, long-lived tangible assets, or right-of-use assets to become impaired
- 04Our uneven sales cycle makes planning and inventory management difficult and future financial results less predictable
- 05The variety of products that we sell could cause significant quarterly fluctuations in our gross profit margins, and those fluctuations in margins could cause fluctuations in operating income or loss and net income or loss
- 06Our products and services may experience quality problems from time to time that can result in decreased sales and operating margin, product returns, product liability, and warranty or other claims that could result in significant expenses and harm to our reputation
- 07We purchase components and sub-assemblies for our printers from third-party suppliers that we provide to our customers as spare parts. Additionally, we purchase raw chemicals and packaging that are used in our materials, as well as certain of those materials, from third-party suppliers
- 08Periodic delays on the inbound supply chain at our partners and our own facilities have also created challenges. We continue to identify alternative solutions, but an inability to source from alternative suppliers in a timely manner could impact our ability to fulfill demand
- 09In areas of operations that involve handling hazardous materials, failure to maintain safe working conditions could result in workplace injuries, regulatory penalties, and reputational harm, as well as increased costs related to litigation, insurance, and compliance
- 10We cannot assure you that we will generate cash from operations or identify and secure other potential sources to fund future working capital needs and meet capital expenditure requirements
- 11Our business could be adversely impacted in the event of a failure of our information technology infrastructure or a successful cyber-attack
- 12The indenture governing the Notes (the "Indenture") contains covenants that impose significant restrictions on us, and the failure to comply with these covenants could result in an event of default under these instruments
- 13Our operations and business performance could suffer if we are unable to attract and retain senior management or other key employees
- 14Business Strategy Risk Factors
- 15We believe that our future success depends on our ability to deliver products and services that meet changing technology and customer needs
- 16The success of our regenerative medicine efforts depends on developing and commercializing products, either ourselves or in conjunction with development partners, that are subject to technical and market risks
- 17Regulatory, Legislative and Legal Risk Factors
- 18We are subject to complex government laws and regulations relating to certain product sets and failure to meet the stringent requirements could impact our business operations and financial position
- 19In February 2023, the Company settled these matters with all three agencies. See Note 22, “Commitments and Contingencies,” to our consolidated financial statements included in Part II, Item 8, “Financial Statements and Supplementary Data” of this Form 10-K for additional information
- 20We derive a significant portion of our revenue from business conducted outside the U.S. and are subject to the risks of doing business outside the U.S
- 21The consequences of terrorism or armed conflicts are unpredictable, and we may not be able to foresee events that could have an adverse effect on our market opportunities or our business. We are uninsured for losses and interruptions caused by terrorism, acts of war and similar events
- 22We may incur substantial costs enforcing or acquiring intellectual property rights and defending against third-party claims as a result of litigation or other proceedings
- 23We may not be able to protect our intellectual property rights and confidential information, including our digital content, from third-party infringers or unauthorized copying, use or disclosure
- 24Changes in, or interpretation of, tax rules and regulations may impact our effective tax rate and future profitability
- 25We are no longer eligible to use a Form S-3 registration statement, which could impair our capital-raising activities
Other 3d Systems 10-Ks
- FY2025 10-K risk factors23 risks3 new5 dropped10 reworded
Customer concentration shifted from one large client to two Healthcare Solutions clients representing 12.2% and 11.4% of revenue. Climate and weather supply chain disruptions were added as a new risk. Export control settlement obligations with BIS, DDTC, and ITAR were resolved.
Filed Mar 09, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.